5 Stocks Pulling The Health Services Industry Downward

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 68 points (-0.5%) at 14,443 as of Monday, March 25, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,111 issues advancing vs. 1,777 declining with 156 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Vanguard Health Systems ( VHS), down 6.7%, Mettler-Toledo International ( MTD), down 2.4%, Edwards Life ( EW), down 1.2%, Boston Scientific ( BSX), down 1.1% and Thermo Fisher Scientific ( TMO), down 1.0%. Top gainers within the industry include HCA Holdings ( HCA), up 1.4%, Aetna ( AET), up 0.7% and UnitedHealth Group ( UNH), up 0.7%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today:

5. PerkinElmer ( PKI) is one of the companies pushing the Health Services industry lower today. As of noon trading, PerkinElmer is down $0.85 (-2.5%) to $33.17 on heavy volume Thus far, 846,346 shares of PerkinElmer exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $32.90-$34.22 after having opened the day at $34.08 as compared to the previous trading day's close of $34.02.

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. PerkinElmer has a market cap of $4.0 billion and is part of the health care sector. The company has a P/E ratio of 58.4, above the S&P 500 P/E ratio of 17.7. Shares are up 8.1% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate PerkinElmer a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full PerkinElmer Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Medical Imaging Unit Sale Could Be in the Works

Trade-Ideas: PerkinElmer (PKI) Is Today's "Barbarian At The Gate" Stock

Jim Cramer's 'Mad Money' Recap: Short-Term Pain? Try Investing for Long-Term Gain